Skip to content

High-density mapping of intracardiac electrograms for arrhythmogenic substrate identification in human atrial fibrillation

High-density mapping of intracardiac electrograms for arrhythmogenic substrate identification in human atrial fibrillation - HIDEC-AF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040849
Enrollment
80
Registered
2026-07-07
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

persistent atrial fibrillation

Interventions

Group 1: Patients between 18 and 85 years of age planned for a first ablation for persistent atrial fibrillation or having received one previous ablation with sole isolation of the pulmoray veins.

Sponsors

TUM Klinikum Deutsches Herzzentrum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Patient is able and willing to comply with the protocol requirements - Written informed consent - Planned first ablation for persistent atrial fibrillation or one previous ablation with sole isolation of the pulmonary veins (no further atrial substrate modification)

Exclusion criteria

Exclusion criteria: - Previous left-atrial substrate modification - Previous cardiac surgery potentially alternating the atrial substrate - Paroxysmal or permanent atrial fibrillation - Any cardiac ablation less than 2 months ago

Design outcomes

Primary

MeasureTime frame
Reliable and reproducible identification of presence , extent and distribution of abnormal electrogram patterns during atrial fibrillation including abnormal peak frequency, voltage, conduction velocity, dispersions, near-field electrograms and emphasis mapping.

Secondary

MeasureTime frame
(1) comparison of the identified regions between patients with prior AF ablation and without prior AF ablation, (2) association between identified substrate and arrhythmia recurrence during follow-up and (3) analysis of additional signal characteristics (activation vectors, fractionation, repetitiveness, electrogram duration, peak frequency gradient, comparison with currently available mapping algorithms) in identified regions.

Countries

Germany

Contacts

Public ContactIsabel Deisenhofer

TUM Klinikum Deutsches Herzzentrum

MARS@dhm.mhn.de+49 89 1218 3093

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026